Medical Grade Injection Molding: What You Need to Know About FDA Compliance
Sourcing plastic injection-molded components for a medical device is fundamentally different from sourcing industrial parts. The stakes — patient safety, regulatory approval, product liability — demand a different level of rigor from both the buyer and the supplier. This guide covers what medical device OEMs and their supply chain teams need to understand before selecting a plastic molding supplier.
What “FDA Compliant” Actually Means for Molded Parts
“FDA compliant” is a term that gets used loosely. For plastic injection-molded components used in medical devices, compliance typically refers to one or more of the following:
1. FDA 21 CFR Resin Compliance
The FDA regulates plastic materials that may come into contact with food or drugs. For medical device components that contact the body or biological fluids indirectly, the relevant standard is 21 CFR (Code of Federal Regulations) — specifically regulations for food contact plastics (21 CFR 177) and indirect food additives.
Important: 21 CFR compliance means the resin formulation is compliant — it does not automatically make a molded part or device FDA-cleared. Device-level FDA clearance (510(k), PMA) is the responsibility of the device manufacturer.
2. USP Class VI Biocompatibility
The US Pharmacopeia Class VI biological test is the most commonly specified biocompatibility standard for plastic resins used in medical applications. USP Class VI tests assess systemic toxicity, intracutaneous reactivity, and implantation in biological systems.
USP Class VI is a material-level test on the resin itself — suppliers provide a certificate of compliance from the resin manufacturer. It does not certify the final molded part.
Common USP Class VI certified resins:
- Polypropylene (PP) — the most widely used
- Polyethylene (HDPE, LDPE)
- Polycarbonate (PC) — including BPA-free grades
- ABS (medical grade)
- PEEK
- POM (polyacetal)
- TPE / TPU (medical grades)
- PMMA (medical grade)
3. ISO 10993 Biocompatibility Testing
ISO 10993 is the international standard for the biological evaluation of medical devices. Unlike USP Class VI (which tests the raw material), ISO 10993 testing can be applied to the finished molded part.
For Class I and Class II devices (most non-implantable devices), the risk-based approach allows reference to resin-level USP Class VI data combined with a biocompatibility risk assessment rather than full device-level ISO 10993 testing. Your regulatory affairs team should determine the specific testing path for your device classification and market.
Material Selection for Medical Molding
Key Criteria
When selecting a resin for a medical-grade molded part, evaluate:
- Biocompatibility — does the resin have USP Class VI or ISO 10993 data?
- Sterilization compatibility — EtO, gamma, steam autoclave, or e-beam?
- Chemical compatibility — will the part contact disinfectants, body fluids, or reagents?
- Mechanical properties — impact, flexural, tensile strength for the application
- Regulatory extractables — are there any residual monomers or additives that could leach?
Sterilization Compatibility by Material
| Material | EtO | Gamma | Steam (121°C) | E-beam |
|---|---|---|---|---|
| PP (medical) | ✅ | Limited* | ✅ | ✅ |
| PE (HDPE) | ✅ | ✅ | ❌ | ✅ |
| PC (medical) | ✅ | ✅ | Limited** | ✅ |
| ABS (medical) | ✅ | ❌ | ❌ | ❌ |
| PEEK | ✅ | ✅ | ✅ (134°C) | ✅ |
| POM | ✅ | ✅ | ✅ (121°C) | ✅ |
| TPE/TPU (medical) | ✅ | Depends on grade | Depends | Depends |
*PP requires gamma-stabilized grade for radiation sterilization.
**PC can withstand limited steam sterilization cycles at 121°C; consult resin supplier for cycle count limitations.
Supplier Requirements for Medical Molding
Choosing a medical molding supplier requires evaluating beyond ISO 9001. Questions to ask:
Quality System
- ISO 9001:2015 — minimum baseline
- ISO 13485 — medical device quality management system, increasingly required by medical OEMs and required for some markets (EU MDR)
- Does the supplier have a documented change control process? Any change to material, process, or tooling must be documented and — depending on your device classification — may require notification to your quality team
Material Traceability
Every production lot of medical components should be traceable to:
- Specific resin lot number
- Resin compliance certificate (USP Class VI, ISO 10993 reference)
- Processing date and machine
- Inspection records
This data supports your Device History Record (DHR) and is essential for any post-market quality event.
Clean Room Capability
Not every medical molded part requires clean room production. The decision depends on:
- Is the part a sterile component? (If sterilized downstream, clean room reduces bioburden before sterilization)
- Is the part a component in a clean room-assembled device?
- What is the contamination risk from the molded part’s surface?
For parts requiring clean room molding, minimum requirements are typically:
- ISO 8 / Class 100,000 — for most medical device components
- ISO 7 / Class 10,000 — for components of sterile medical devices
Documentation Package
For medical programs, your supplier should be able to provide:
- Certificate of Conformance per shipment
- First Article Inspection report (dimensional data)
- Material certificate (per lot, with USP/ISO compliance)
- Process records (injection parameters per production run)
- Non-conformance and CAPA records on request
Common Mistakes Medical OEMs Make When Sourcing Molded Parts
1. Accepting “FDA compliant” without specifying which standard Ask specifically for USP Class VI certificate or ISO 10993 reference data — not a general “FDA compliant” claim.
2. Not specifying sterilization method to the molder The mold design (e.g. surface finish, material flow, areas where stress is concentrated) should account for sterilization-induced degradation. Tell your supplier the sterilization method at the design stage.
3. Skipping DFM review for medical parts Medical parts often have fine features — thin walls, precise snap-fits, small diameter ports. DFM review is more important here, not less, because failures in medical applications have consequences beyond warranty claims.
4. Not establishing a change control protocol Agree with your supplier in writing that any change to material, process parameters, or tooling requires written notification and your approval before implementation. This is a non-negotiable requirement for medical supply chains.
How JBRplas Supports Medical Programs
JBRplas operates a Class 100,000 (ISO 8) clean room molding facility and maintains material traceability records to lot level for all medical programs. We supply documented First Article Inspection reports, CoC, and material certificates as standard for medical customers.
We work with engineering teams to review biocompatibility requirements at the design stage — before tooling — to avoid costly late-stage material changes.